FDA Clearance Tracker · P990071-S013
THERMOCOOL SF NAV UNI-DIRECTIONAL CATHETER (D-1315-XX-S, D-1318-XX-S) AND THERMOCOOL SF UNI-DIRECTIONAL CATHETER
Last checked: Nov 20, 2026Latest source record: Dec 21, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2011
Approved
Time to decision
184 days
Received Jun 20, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P990071-S013
- Device name
- THERMOCOOL SF NAV UNI-DIRECTIONAL CATHETER (D-1315-XX-S, D-1318-XX-S) AND THERMOCOOL SF UNI-DIRECTIONAL CATHETER
- Applicant
- Biosense Webster, Inc.
- Applicant location
- Irvine, CA
- Received
- Jun 20, 2011
- Decided
- Dec 21, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P990071
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE FOLLOWING MODIFICATIONS: 1) REDUCED RECOMMENDED SALINE FLOW RATE (REDUCE BY ~50%; 2) INCREASE IN NUMBER OF IRRIGATION HOLES (FROM 6 TO 56); 3) DECREASE IN SIZE OF IRRIGATION HOLES (FROM 0.016¿ TO 0.0035¿ DIAMETER); AND 4) MODIFIED TIP ELECTRODE MATERIAL (FROM 90% PLATINUM/10% IRIDIUM TO 80% PALLADIUM/20% PLATINUM).THE DEVICE, AS MODIFIED WILL BE MARKETED UNDER THE TRADE NAMES UNI-DIRECTIONAL CARTO XP THERMOCOOL SF NAV CATHETER, UNI-DIRECTIONAL CARTO 3 THERMOCOOL SF NAV CATHETER, AND UNI-DIRECTIONAL THERMOCOOL SF CATHETER AND IS INDICATED FOR CATHETER BASED CARDIAC ELECTROPHYSIOLOGICAL MAPPING (STIMULATING AND RECORDING) AND, WHEN USED WITH A COMPATIBLE RT GENERATOR, FOR THE TREATMENT OF: A) TYPE I ATRIAL FLUTTER IN PATIENTS AGE 18 OR OLDER; B) DRUG REFRACTORY RECURRENT SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION, WHEN USED WITH COMPATIBLE THREE-DIMENSIONAL ELECTROANATOMIC MAPPING SYSTEMS. THE THERMOCOOL SF NAV DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER PROVIDES LOCATION INFORMATION WHEN USED WITH COMPATIBLE CARTO EP NAVIGATION SSYTEMS. THE BIOSENSE WEBSTER THERMOCOOL SF DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER AND RELATED ACCESSORIES ARE INDICATED FOR USE IN CATHETER-BASED CARDIAC ELECTROPHYSIOLOGICAL MAPPING (STIMULATING AND RECORDING) AND, WHEN USED WITH A COMPATIBLE RF GENERATOR, FOR THE TREATMENT OF TYPE I ATRIAL FLUTTER IN PATIENTS AGE 18 OR OLDER.
Source documents
Other decisions for Biosense Webster, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Dual Energy THERMOCOOL SMARTTOUCH SF SystemPMA supplement
P030031-S141 · Decided Jul 1, 2026 · 279 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.